ABSTRACT
Objective To observe the clinical efficacy of electroencephalogram (EEG)-guided scalp acupuncture plus body acupuncture in treating epilepsy.Method Sixty epilepsy patients in interictal stage were randomized into a guided acupuncture group, a body acupuncture group, and a Western medication group. The guided acupuncture group was given scalp plus body acupuncture under the guidance of EEG; the body acupuncture group was given ordinary body acupuncture treatment; the Western medication group didn't receive acupuncture treatment. The clinical efficacy was evaluated; before and after the treatment, the powers ofα,β,θ andδ bands and interictal epileptic activity (IEA) were observed by EEG and brain electrical activity mapping (BEAM).Result After the treatment, IEA declined significantly in all cases according to EEG (P<0.05), while the guided acupuncture group was insignificantly different from the other two groups in comparing IEA (P>0.05). In the guided acupuncture group and body acupuncture group, the absolute powers ofα1,α2 andβ2 bands were significantly improved, and the powers ofθ andδ bands were decreased significantly (P<0.05); the values of these two groups were significantly different from those of the Western medication group (P<0.05), but the guided acupuncture group showed a more significant effect in improving EEG power spectrum compared to the body acupuncture group (P<0.05).Conclusion EEG-guided scalp plus body acupuncture is effective in treating epilepsy, which is possibly related to the inhibition of IEA and improvement of EEG power spectrum.
ABSTRACT
Objective To observe the clinical efficacy of electroencephalogram (EEG)-guided scalp acupuncture plus body acupuncture in treating epilepsy.Method Sixty epilepsy patients in interictal stage were randomized into a guided acupuncture group, a body acupuncture group, and a Western medication group. The guided acupuncture group was given scalp plus body acupuncture under the guidance of EEG; the body acupuncture group was given ordinary body acupuncture treatment; the Western medication group didn't receive acupuncture treatment. The clinical efficacy was evaluated; before and after the treatment, the powers ofα,β,θ andδ bands and interictal epileptic activity (IEA) were observed by EEG and brain electrical activity mapping (BEAM).Result After the treatment, IEA declined significantly in all cases according to EEG (P<0.05), while the guided acupuncture group was insignificantly different from the other two groups in comparing IEA (P>0.05). In the guided acupuncture group and body acupuncture group, the absolute powers ofα1,α2 andβ2 bands were significantly improved, and the powers ofθ andδ bands were decreased significantly (P<0.05); the values of these two groups were significantly different from those of the Western medication group (P<0.05), but the guided acupuncture group showed a more significant effect in improving EEG power spectrum compared to the body acupuncture group (P<0.05).Conclusion EEG-guided scalp plus body acupuncture is effective in treating epilepsy, which is possibly related to the inhibition of IEA and improvement of EEG power spectrum.
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the efficacy and safety of Yindan Xinnaotong Soft Capsule (YXSC) on cerebral infarction (CI) reconvalescents of static blood blocking collaterals syndrome (SBBCS).</p><p><b>METHODS</b>Totally 118 CI reconvalescents of SBBCS were randomly assigned to the test group (treated by YXSC) and the control group [treated by Naoxintong Capsule (NC)], 59 in each group. The therapeutic course for all was 12 weeks. Changes of National Institute of Health Stroke Scale (NIHSS), Barthel Index (BI), modified Rankin Scale (mRS), Chinese medical syndrome scores, and serum lipid indices were observed in the two groups.</p><p><b>RESULTS</b>Compared with the control group, the patient proportion of improving activities of daily life by more than or equal to 75 score was elevated (80.7% vs 62.5%; P < 0.05). Compared with before treatment in the same group, the NIHSS score decreased at post-treatment 4, 8, and 12 weeks in the two groups (P < 0.05). The patient proportion of dropped NIHSS score by more than or equal to 5 score was lowered (80.7% vs 57.14%), and the total effective rate of improving Chinese medical syndromes was superior in the test group after 12-week treatment (89.47% vs 71.43%, all P < 0.05). After 12-week treatment there was no statistical difference in the patient proportion of lowering mRS lower than or equal to 2 or blood lipids between the two groups (P > 0.05).</p><p><b>CONCLUSION</b>YXSC showed certain effect in improving activities of daily life, attenuating the neurological impairment, and elevating the total effective rate of improving Chinese medical syndromes in CI patients in the recovery stage.</p>